GBGT1 and myocardial infarction: Abnormal regulation of SLE andMAPK metabolic pathways might have a significant impact on the occurrence of MI.CYP4F3/TBL1XR1/GBGT1/USP25/FDFT1/RORA expression could possiblybe used as markers for the diagnosis of AMI, and hopefully, suggest new methods whenbeing used as clinical targets for the treatment of AMI patients.